NASDAQ:BGM - KYG7307E1237 - Common Stock
BGM gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 193 industry peers in the Pharmaceuticals industry. BGM has a great financial health rating, but its profitability evaluates not so good. BGM is valued expensive and it does not seem to be growing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -2.72% | ||
ROE | -3.38% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 16.39% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | 78.07 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 3.39 | ||
Quick Ratio | 2.82 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | 1914.85 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:BGM (8/26/2025, 8:16:43 PM)
8.1
+0.07 (+0.87%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 52.43 | ||
P/FCF | N/A | ||
P/OCF | 2418.09 | ||
P/B | 30.79 | ||
P/tB | 34.44 | ||
EV/EBITDA | 1914.85 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -2.72% | ||
ROE | -3.38% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 16.39% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | 0 | ||
Cap/Depr | 106.56% | ||
Cap/Sales | 5.25% | ||
Interest Coverage | N/A | ||
Cash Conversion | 80.81% | ||
Profit Quality | N/A | ||
Current Ratio | 3.39 | ||
Quick Ratio | 2.82 | ||
Altman-Z | 78.07 |